Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Brent Boleslav
Institution:
University at Buffalo, State University of New York
Observed institution:
University at Buffalo, State University of New York
ORCID:
0000-0002-5521-5493
Observed ORCID:
0000-0002-5521-5493
OpenAlex ID:
A5117321735
Insights and perspectives into the etiology of TKI-induced cardiotoxicity
2026
·
Vivian Xu
, Bagdad Ahmed
, et al.
·
ASPET Discovery
·
1
Abstract LB005: Synergistic effect of tamoxifen and doxorubicin on a novel estrogen receptorβ-p53-p73 axis: A new therapeutic strategy against triple negative breast cancer cancer
2025
·
Gokul M. Das
, Chetan C. Oturkar
, et al.
·
Cancer Research
·
1
Tamoxifen and Doxorubicin Synergistically Target Estrogen Receptor β-Mutant p53-p73 Axis, a Therapeutically Actionable Vulnerability in Triple Negative Breast Cancer
2026
·
Chetan C Oturkar
, Junhoung Park J
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Abstract LB058: Clinically actionable drug synergy drives transcriptomic and metabolic reprogramming to induce ferroptosis and apoptosis in triple negative breast cancer
2026
·
Gokul M. Das
, Chetan C. Oturkar
, et al.
·
Cancer Research
Show more works
View as search
Works count:
4
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type